HL7 Terminology (THO)
6.0.2 - Publication
This page is part of the HL7 Terminology (v6.0.2: Release) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Active as of 2024-07-21 | Maturity Level: 3 |
{
"resourceType" : "CodeSystem",
"id" : "allergyintolerance-clinical",
"meta" : {
"lastUpdated" : "2024-04-24T00:00:00+00:00",
"profile" : [
🔗 "http://hl7.org/fhir/StructureDefinition/shareablecodesystem"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem allergyintolerance-clinical</b></p><a name=\"allergyintolerance-clinical\"> </a><a name=\"hcallergyintolerance-clinical\"> </a><a name=\"allergyintolerance-clinical-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Last updated: 2024-04-24 00:00:00+0000</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"http://hl7.org/fhir/R5/shareablecodesystem.html\">Shareable CodeSystem</a></p></div><p>This case-sensitive code system <code>http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical</code> defines the following codes in an undefined hierarchy:</p><table class=\"codes\"><tr><td><b>Lvl</b></td><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td>1</td><td style=\"white-space:nowrap\">active<a name=\"allergyintolerance-clinical-active\"> </a></td><td>Active</td><td>The subject is currently experiencing, or is at risk of, a reaction to the identified substance.</td></tr><tr><td>1</td><td style=\"white-space:nowrap\">inactive<a name=\"allergyintolerance-clinical-inactive\"> </a></td><td>Inactive</td><td>The subject is no longer at risk of a reaction to the identified substance.</td></tr><tr><td>2</td><td style=\"white-space:nowrap\">\u00a0\u00a0resolved<a name=\"allergyintolerance-clinical-resolved\"> </a></td><td>Resolved</td><td>A reaction to the identified substance has been clinically reassessed by testing or re-exposure and is considered no longer to be present. Re-exposure could be accidental, unplanned, or outside of any clinical setting.</td></tr></table></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode" : "pc"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger" : 3
}
],
"url" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.4.642.1.1373"
}
],
"version" : "1.0.1",
"name" : "AllergyIntoleranceClinicalStatusCodes",
"title" : "AllergyIntolerance Clinical Status Codes",
"status" : "active",
"experimental" : false,
"date" : "2024-07-21T00:36:31-06:00",
"publisher" : "Health Level Seven International",
"contact" : [
{
"telecom" : [
{
"system" : "url",
"value" : "http://hl7.org"
},
{
"system" : "email",
"value" : "hq@HL7.org"
}
]
}
],
"description" : "Preferred value set for AllergyIntolerance Clinical Status.",
"copyright" : "This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license",
"caseSensitive" : true,
"valueSet" : "http://terminology.hl7.org/ValueSet/allergyintolerance-clinical",
"content" : "complete",
"concept" : [
{
"code" : "active",
"display" : "Active",
"definition" : "The subject is currently experiencing, or is at risk of, a reaction to the identified substance."
},
{
"code" : "inactive",
"display" : "Inactive",
"definition" : "The subject is no longer at risk of a reaction to the identified substance.",
"concept" : [
{
"code" : "resolved",
"display" : "Resolved",
"definition" : "A reaction to the identified substance has been clinically reassessed by testing or re-exposure and is considered no longer to be present. Re-exposure could be accidental, unplanned, or outside of any clinical setting."
}
]
}
]
}